Merck & Co Inc (MRK)
19 Dec 2014
|Market Cap (Mil.):||$169,855.00|
|Shares Outstanding (Mil.):||2,850.87|
* GSK vaccine cuts risk of shingles by 97.2 pct in over 50s
- Tetraphase Pharmaceuticals Inc said its antibiotic to treat complicated intra-abdominal infections was as effective as Merck & Co Inc's ertapenem in a late-stage study.
* Shares rise 17.5 pct in extended trading (Adds details from conference call, analyst quotes)
Dec 17 - Tetraphase Pharmaceuticals Inc said its antibiotic drug to treat complicated intra-abdominal infections was as effective as Merck & co Inc's ertapenem in a late-stage study.
NEW YORK, Dec 15 - Merck & Co Inc is approaching banks about an $8 billion, 364-day bridge loan that will back the drugmaker's plans to acquire Cubist Pharmaceuticals Inc, sources told Thomson Reuters LPC.
(Corrects paragraph 4 to say Merck Ltd is a unit of Merck KGaA, not Merck & Co Inc)
* Lausanne says safety data "satisfactory" in GSK vaccine trial (Adds statement on GSK Ebola vaccine, new paras 4-7)
* Further funding of up to $90 mln to help vaccine roll-out (Wraps stories on GAVI funding, NewLink vaccine trial, adds GAVI CEO comment)
* Debate over "prime-boost" vaccination as epidemic evolves
Dec 9 - In its planned purchase of antibiotics maker Cubist Pharmaceuticals Inc, Merck & Co will gain a sales force well placed to propel its own experimental drug for an intestinal bug, C. difficile, that is a scourge among hospital patients.
Earnings vs. Estimates
Analyst Research Reports
Provider: Thomson Reuters Stock Report
Trading Report for (MRK). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
Provider: New Constructs, LLC
"The Economy Matters" Report for MRK: the economy's impact on MRK's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score
Provider: MacroRisk Analytics/EconomicInvestor
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.